Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 177

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Short-term Pulmonary Vasodilation With l-Arginine in Pulmonary Hypertension

Mehta, Sanjay, Stewart, Duncan J., Langleben, David, Levy, Robert D. · 1995 · Circulation

Abstract

Background Endothelial dysfunction may contribute to the pathogenesis of pulmonary hypertension through impaired production of the endothelium-derived vasodilator nitric oxide (NO).l-Arginine, the substrate for NO synthase (NOS), has a vasodilatory effect in systemic vascular beds and can correct abnormal endothelium-dependent vasodilation. It has been suggested that these two effects of l-arginine are mediated through NOS metabolism and enhanced NO production. Therefore, we assessed the short-term pulmonary hemodynamic effects of exogenous l-arginine in patients with pulmonary hypertension of various origins. Methods and Results During continuous hemodynamic monitoring, 10 subjects with pulmonary hypertension (mean pulmonary artery pressure [PAP], 54±5 mm Hg [mean±SEM]) received a 30-minute control infusion of hypertonic saline followed by a 30-minute infusion of 500 mg/kg of l-arginine. The hemodynamic effects of l-arginine were compared with those of prostacyclin titrated to maximally tolerated doses. The hemodynamic response to l-arginine was also studied in 5 subjects with heart failure but without pulmonary hypertension (mean PAP, 20±2 mm Hg) and 5 healthy control subjects. In subjects with pulmonary hypertension, infusion of l-arginine reduced mean PAP by 15.8±3.6% (P<.005) and pulmonary vascular resistance (PVR) by 27.6±5.8% (P<.005) compared with decreases of 13.0±5.5% (P<.005) and 46.6±6.2% (P<.005), respectively, with prostacyclin.l-Arginine infusion also increased the mean plasma level of l-arginine from 59±6 μmol/L to 10 726±868 μmol/L (P<.005), which was associated with a significant increase in the plasma level of l-citrulline, the immediate product of NOS metabolism of l-arginine. Moreover, the peak plasma level of l-citrulline correlated significantly with the reductions in mean PAP (r=.71,P<.05) and PVR (r=.70,P<.05), consistent with vasodilation mediated by NOS metabolism of exogenous l-arginine and increased NO production.l-Arginine also had a modest hypotensive effect in healthy control subjects and reduced systemic vascular resistance in subjects with heart failure in the absence of pulmonary hypertension. However, only small reductions in absolute pulmonary vascular resistance were observed in this latter group in response to l-arginine that did not reach significance. Conclusions An exaggerated short-term pulmonary vasodilatory response to l-arginine in patients with pulmonary hypertension suggests a relative impairment in pulmonary vascular endothelial NO production that may contribute to increased pulmonary vascular tone and thus be important in the pathophysiology of pulmonary hypertension.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.92.6.1539

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 177

Metadata

Authors
Mehta, S., Stewart, D. J., Langleben, D., & Levy, R. D.
Venue
Circulation
Published
1995-09-15
Volume
92
Issue
6
Pages
1539-1545
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W1975961217
Cited by
177
References
1
FWCI
4.16
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Short-term Pulmonary Vasodilation With l-Arginine in Pulmonary Hypertension. https://app.cochat.ai/papers/10.1161/01.cir.92.6.1539
The paper
Mehta, S., Stewart, D. J., Langleben, D., & Levy, R. D. (1995). Short-term Pulmonary Vasodilation With l-Arginine in Pulmonary Hypertension. Circulation. https://doi.org/10.1161/01.cir.92.6.1539

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.